Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01263626 · ClinicalTrials.gov registry record

Cough Monitoring Study

A clinical trial, sponsored by Vanderbilt University.

Completed
Registry status
33
Enrollment target

NCT01263626: Completed study, sponsored by Vanderbilt University.

NCT01263626 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01263626 has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
33 participants
Enrollment target

Study Summary

The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes. Cough is an important defense mechanism of the respiratory tract. The presence of chronic cough may indicate the presence of underlying diseases, including reflux. Despite the increased number of patients suffering from cough in the ENT and GI practice, to date, there has been no method/device to objectively assess the frequency of cough episodes in a given patient. PULMOTRACK-CC, manufactured by KarmelSonix (Haifa, Israel), has recently introduced an innovative device that is able to record cough episodes and then automatically detect and count them with the help of a specific software program. This study will assess the accuracy of this novel cough monitoring and counting technology and validate potential clinical use in patients with chronic cough.

Primary Outcome

The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes.

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2010-11
Est. Completion 2014-12
Vanderbilt University

430 total trials

What the finished NCT01263626 record still lists

NCT01263626 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01263626 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01263626 about?

NCT01263626 is a clinical study titled "Cough Monitoring Study". The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes. Cough is an important defense mechanism of the respiratory tract. The presence of chronic cough may indicate the presence of underlying diseases, including reflux. Despite th...

What is the current status of trial NCT01263626?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2010-11. Estimated completion is 2014-12.

Who is sponsoring clinical trial NCT01263626?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01263626, the US trial registry maintained by the National Library of Medicine. NCT01263626 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.